Inventor · disambiguated record
Yasutsugu Ueda
Also filed as: UEDA YASUTSUGU
34 granted patents·26 pending applications·827 citations·filing 1978–2020
98Inventor score
Files withBRISTOL MYERS SQUIBB CO41VIIV HEALTHCARE UK NO 4 LTD5BRISTOL MYERS CO3WANG TAO3UEDA YASUTSUGU2
Top patents by PatentIndex Score
60 records- 0198US7354924B2Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 8, 2008·106 cites·6 claims
- 0297US7745625B2Prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 29, 2010·62 cites·7 claims
- 0397US7662823B2Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 16, 2010·17 cites·8 claims
- 0497US7501420B2Composition and antiviral of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 10, 2009·21 cites·10 claims
- 0597US7419969B2HIV integrase inhibitors: cyclic pyrimidinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 2, 2008·61 cites·6 claims
- 0697US5272171APhosphonooxy and carbonate derivatives of taxolBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Dec 21, 1993·155 cites·52 claims
- 0796US6235728B1Water-soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 22, 2001·81 cites·6 claims
- 0895US7157447B2Bicyclic heterocycles as HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jan 2, 2007·30 cites·5 claims
- 0994US7176196B2Bicyclic heterocycles as HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 13, 2007·35 cites·27 claims
- 1093US7173022B2Bicyclic heterocycles as HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 6, 2007·31 cites·14 claims
- 1192US8168615B2Prodrugs of piperazine and substituted piperidine antiviral agentsUEDA YASUTSUGU·Filed 2010·Granted May 1, 2012·14 cites·1 claims
- 1292US7135467B2HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 14, 2006·34 cites·29 claims
- 1391US8461333B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsUEDA YASUTSUGU·Filed 2012·Granted Jun 11, 2013·12 cites·2 claims
- 1488US7960406B2Diketo substituted pyrrolo[2,3-c] pyridinesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jun 14, 2011·5 cites·4 claims
- 1587US8871771B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 28, 2014·5 cites·1 claims
- 1685US7511037B2N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitorBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 31, 2009·7 cites·4 claims
- 1785US4182711AAntibacterial agents of the β-lactam typeBRISTOL MYERS CO·Filed 1978·Granted Jan 8, 1980·15 cites·17 claims
- 1884US7902182B2HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 8, 2011·4 cites·9 claims
- 1982US8124615B2Diketo substituted pyrrolo[2,3-C]pyridinesWANG TAO·Filed 2011·Granted Feb 28, 2012·3 cites·6 claims
- 2082US6362172B2Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 26, 2002·17 cites·18 claims
- 2181US8129398B2HIV integrase inhibitorsBEAULIEU FRANCIS·Filed 2009·Granted Mar 6, 2012·12 cites·17 claims
- 2281US5620969ACephalosporin derviativesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Apr 15, 1997·24 cites·17 claims
- 2378US7893055B2HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 22, 2011·4 cites·7 claims
- 2477US6093712ACephalosporin derivativesBRISTOL MEYERS SQUIBB CO·Filed 1998·Granted Jul 25, 2000·21 cites·9 claims
- 2576US11369624B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2020·Granted Jun 28, 2022·0 cites·1 claims
- 2675US8039458B2HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 18, 2011·2 cites·14 claims
- 2775US2014135342A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2874US6265394B1Bis quaternary MRSA cephem derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 24, 2001·19 cites·22 claims
- 2974US2015087652A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3073US2010093752A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 3173US2013289046A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 3272US2020046743A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Application pending·0 cites
- 3371US7022667B2O-derivatized nocathiacin derivativesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 4, 2006·5 cites·9 claims
- 3470US2016207918A1Substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3570US2012238583A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsWANG TAO·Filed 2012·Application pending·0 cites
- 3670US2019111066A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2018·Application pending·0 cites
- 3770US2016152615A1Prodrugs of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3869US4683296ACarbapenem intermediatesBRISTOL MYERS CO·Filed 1985·Granted Jul 28, 1987·10 cites·3 claims
- 3969US2016075703A1Substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4069US2013030005A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 4168US2015329543A1Prodrugs of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4267US2015025240A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 4366US2018000849A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK (NO 4) LTD·Filed 2017·Application pending·0 cites
- 4466US2015259342A1Substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4566US2011245268A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 4665US2004110785A1Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivativesFiled 2003·Application pending·0 cites
- 4765US2011118279A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 4864US2012095017A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsWANG TAO·Filed 2011·Application pending·0 cites
- 4963US2016361328A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 5061US2015315218A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →